- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Tablet PC and digital pen trump PDA for data entry
Researchers may be ready to set aside traditional pen and paper for entering data in large clinical trials. Not only do investigators prefer their digital counterparts, but those devices also lead to a reduction in data entry errors.
Researchers may be ready to set aside traditional pen and paper for entering data in large clinical trials. Not only do investigators prefer their digital counterparts, but those devices also lead to a reduction in data entry errors.
At the 2004 RSNA meeting, researchers from the University of North Carolina, Chapel Hill compared a Tablet PC, digital pen, PDA/digitizer hybrid, and traditional PDA in terms of speed, ease of use, accuracy, and user satisfaction.
Pen and paper entry was used as a control. The standard paper control was the fastest method of data entry, at an average time of 155.2 seconds per case. The stand-alone PDA had the slowest result, at an average of 276.6 seconds for complete entry.
The researchers found no statistically significant difference between data entry times for the digital pen, pen and paper, and the Tablet PC.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
